AU2002327831A1 - Transdermal therapeutic system based on polyacrylate-contact-bonding adhesives without functional groups - Google Patents
Transdermal therapeutic system based on polyacrylate-contact-bonding adhesives without functional groupsInfo
- Publication number
- AU2002327831A1 AU2002327831A1 AU2002327831A AU2002327831A AU2002327831A1 AU 2002327831 A1 AU2002327831 A1 AU 2002327831A1 AU 2002327831 A AU2002327831 A AU 2002327831A AU 2002327831 A AU2002327831 A AU 2002327831A AU 2002327831 A1 AU2002327831 A1 AU 2002327831A1
- Authority
- AU
- Australia
- Prior art keywords
- polyacrylate
- contact
- functional groups
- system based
- therapeutic system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10141652A DE10141652B4 (en) | 2001-08-24 | 2001-08-24 | Transdermal therapeutic system based on polyacrylate pressure-sensitive adhesives without functional groups and its use |
DE10141652.0 | 2001-08-24 | ||
PCT/EP2002/009057 WO2003017988A1 (en) | 2001-08-24 | 2002-08-13 | Transdermal therapeutic system based on polyacrylate-contact-bonding adhesives without functional groups |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2002327831A1 true AU2002327831A1 (en) | 2003-06-05 |
AU2002327831B2 AU2002327831B2 (en) | 2007-10-25 |
Family
ID=7696570
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002327831A Ceased AU2002327831B2 (en) | 2001-08-24 | 2002-08-13 | Transdermal therapeutic system based on polyacrylate-contact-bonding adhesives without functional groups |
Country Status (14)
Country | Link |
---|---|
US (1) | US20040241219A1 (en) |
EP (1) | EP1418895B1 (en) |
JP (1) | JP4393188B2 (en) |
KR (1) | KR100920599B1 (en) |
CN (1) | CN1239153C (en) |
AU (1) | AU2002327831B2 (en) |
BR (1) | BRPI0211993B8 (en) |
CA (1) | CA2455064C (en) |
DE (1) | DE10141652B4 (en) |
ES (1) | ES2397920T3 (en) |
HK (1) | HK1069533A1 (en) |
MX (1) | MXPA04001677A (en) |
WO (1) | WO2003017988A1 (en) |
ZA (1) | ZA200400312B (en) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9056060B2 (en) | 2000-09-19 | 2015-06-16 | Henkel Ag & Co. Kgaa | Non-reactive adhesive useful in transdermal drug delivery system |
DE10141650C1 (en) * | 2001-08-24 | 2002-11-28 | Lohmann Therapie Syst Lts | Safe transdermal therapeutic system for administration of fentanyl or analogous analgesics, having matrix layer of carboxy group-free polyacrylate adhesive providing high permeation rate |
PL2446881T3 (en) * | 2003-07-24 | 2014-08-29 | Glaxosmithkline Llc | Orally Dissolving Films |
ES2395290T3 (en) * | 2004-04-13 | 2013-02-11 | Nipro Patch Co., Ltd. | Skin-sensitive crosslinkable skin adhesive |
CN1329022C (en) * | 2004-08-31 | 2007-08-01 | 贵州太和制药有限公司 | Hydrophilic biological sticking gel pasting agent and preparation technique thereof |
MX2007011146A (en) * | 2005-03-12 | 2007-11-06 | Unilever Nv | Hair and/or scalp care compositions incorporating visnadin. |
CN1320009C (en) * | 2005-03-24 | 2007-06-06 | 上海交通大学 | Combination of acrylic ester containing ester group including partial radical of hydroxy group |
CN1326894C (en) * | 2005-03-24 | 2007-07-18 | 上海交通大学 | Combination of acrylic ester containing ester group including partial alkoxyl |
CN1320006C (en) * | 2005-03-24 | 2007-06-06 | 上海交通大学 | Combination of acrylic ester containing ester group including partial radical of ester group |
CN1320008C (en) * | 2005-03-24 | 2007-06-06 | 上海交通大学 | Combination of acrylic ester containing ester group including partial radical of carboxyl group |
CN1320005C (en) * | 2005-03-24 | 2007-06-06 | 上海交通大学 | Combination of acrylic ester containing ester group including paraffin base |
DE102006050558B4 (en) | 2006-10-26 | 2009-03-26 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing norelgestromin for contraception and hormone replacement |
KR100956023B1 (en) * | 2007-09-28 | 2010-05-06 | 대화제약 주식회사 | Patches containing tulobuterol for transdermal administration |
DE102008013701A1 (en) * | 2008-03-11 | 2009-09-17 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system with stabilized membrane |
US20100087768A1 (en) * | 2008-10-02 | 2010-04-08 | Forlano Paula | Transdermal drug delivery system for liquid active ingredient |
US10076502B2 (en) | 2009-12-22 | 2018-09-18 | Luye Pharma Ag | Transdermal therapeutic system for administering rivastigmine or derivatives thereof |
ES2670227T3 (en) * | 2009-12-22 | 2018-05-29 | Luye Pharma Ag | Transdermal therapeutic system for the administration of rivastigmine or its derivatives |
CN101967213A (en) * | 2010-09-29 | 2011-02-09 | 北京化工大学 | Preparation method of carboxyl-contained polyacrylic ester with low molecular weight |
HUE027916T2 (en) | 2010-12-14 | 2016-11-28 | Acino Ag | Transdermal therapeutic system for application of an agent |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
PL2782584T3 (en) | 2011-11-23 | 2021-12-13 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10206932B2 (en) | 2014-05-22 | 2019-02-19 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
AU2017239645A1 (en) | 2016-04-01 | 2018-10-18 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
JP6912876B2 (en) * | 2016-10-06 | 2021-08-04 | 三洋化成工業株式会社 | Additives for acrylic pharmaceutical solid formulations |
DE102017115701B4 (en) * | 2017-07-12 | 2022-03-03 | Lts Lohmann Therapie-Systeme Ag | Fampridine TTS |
WO2019068288A1 (en) | 2017-10-04 | 2019-04-11 | Berlimed International Research Gmbh | Product containing active substance and active substance matrix for transdermal active substance delivery and production and use thereof and active substance matrix and production and use thereof |
DE102018130469A1 (en) | 2018-11-30 | 2020-06-04 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system with diffusion barrier |
DE102019120403A1 (en) | 2019-07-29 | 2021-02-04 | Lts Lohmann Therapie-Systeme Ag | Process for the production of pressure-sensitive adhesives for use in a transdermal therapeutic system |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2693212B2 (en) * | 1989-03-28 | 1997-12-24 | 日東電工株式会社 | Tape preparation for disease treatment |
JP2718433B2 (en) * | 1989-09-08 | 1998-02-25 | シグナス インコーポレイテッド | Solid matrix system for transdermal drug delivery |
DE3933460A1 (en) * | 1989-10-06 | 1991-04-18 | Lohmann Therapie Syst Lts | OSTROGEN-ACTIVE PLASTER |
CA2039586A1 (en) * | 1990-05-02 | 1991-11-03 | Marian R. Appelt | Crosslinked pressure-sensitive adhesives tolerant of alcohol-based excipients used in transdermal delivery devices and method of preparing same |
IT1253265B (en) * | 1991-11-25 | 1995-07-14 | Rotta Research Lab | ACRYLIC-BASED ADHESIVE COPOLYMER MATRIX PREPARATION FOR THE TRANSDERMAL EXTRADIOL RELEASE. |
AU663150B2 (en) * | 1991-11-26 | 1995-09-28 | Research Development Foundation | Fetal membrane tubes for nerve and vessel grafts |
DE4301783C1 (en) * | 1993-01-23 | 1994-02-03 | Lohmann Therapie Syst Lts | Transdermal system per admin. of galanthamine - esp. for treatment of Alzheimer's disease and alcohol addiction |
DE4310012A1 (en) * | 1993-03-27 | 1994-09-29 | Roehm Gmbh | Dermal therapeutic system made of a meltable poly (meth) acrylate mixture |
ES2115231T3 (en) * | 1993-04-20 | 1998-06-16 | Hexal Ag | PLASTER WITH ACTIVE SUBSTANCES. |
CA2166780A1 (en) * | 1993-07-08 | 1995-01-19 | Ooi Wong | Monolithic matrix transdermal delivery system |
US5554381A (en) * | 1993-08-09 | 1996-09-10 | Cygnus, Inc. | Low flux matrix system for delivering potent drugs transdermally |
EP0661046B1 (en) * | 1993-12-30 | 1998-09-30 | Rotta Research B.V. | Transdermal patch with isosorbide dinitrate as active ingredient |
DE4403487C2 (en) * | 1994-02-04 | 2003-10-16 | Lohmann Therapie Syst Lts | Pharmaceutical patches with UV-crosslinkable acrylate copolymers |
US5614210A (en) * | 1995-03-31 | 1997-03-25 | Minnesota Mining And Manufacturing Company | Transdermal device for the delivery of alfuzosin |
SE504430C2 (en) | 1995-06-20 | 1997-02-10 | Ericsson Telefon Ab L M | Magazine |
JPH1036265A (en) * | 1996-07-19 | 1998-02-10 | Nitto Denko Corp | Buprenorphine percutaneous absorption preparation |
US5928666A (en) * | 1996-11-12 | 1999-07-27 | Cygnus Inc. | Crystalline form of estradiol and pharmaceutical formulations comprising same |
US6210705B1 (en) * | 1997-12-15 | 2001-04-03 | Noven Pharmaceuticals, Nc. | Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
DE19814084B4 (en) * | 1998-03-30 | 2005-12-22 | Lts Lohmann Therapie-Systeme Ag | D2 agonist-containing transdermal therapeutic system for the treatment of Parkinson's syndrome and process for its preparation |
DE19830651A1 (en) * | 1998-07-09 | 2000-01-13 | Lohmann Therapie Syst Lts | Plaster containing steroids, process for its production and use |
ATE288256T1 (en) * | 1999-01-14 | 2005-02-15 | Noven Pharma | DERMAL COMPOSITIONS |
EP1103260B1 (en) * | 1999-11-29 | 2005-01-26 | Novosis AG | Transdermal system for the administration of clonidine |
DE10032537A1 (en) * | 2000-07-05 | 2002-01-31 | Labtec Gmbh | Dermal system containing 2- (3-benzophenyl) propionic acid |
US9056060B2 (en) * | 2000-09-19 | 2015-06-16 | Henkel Ag & Co. Kgaa | Non-reactive adhesive useful in transdermal drug delivery system |
-
2001
- 2001-08-24 DE DE10141652A patent/DE10141652B4/en not_active Expired - Lifetime
-
2002
- 2002-08-13 EP EP02762444A patent/EP1418895B1/en not_active Revoked
- 2002-08-13 ES ES02762444T patent/ES2397920T3/en not_active Expired - Lifetime
- 2002-08-13 US US10/487,380 patent/US20040241219A1/en not_active Abandoned
- 2002-08-13 JP JP2003522508A patent/JP4393188B2/en not_active Expired - Fee Related
- 2002-08-13 AU AU2002327831A patent/AU2002327831B2/en not_active Ceased
- 2002-08-13 CA CA2455064A patent/CA2455064C/en not_active Expired - Lifetime
- 2002-08-13 WO PCT/EP2002/009057 patent/WO2003017988A1/en active Application Filing
- 2002-08-13 BR BRPI0211993A patent/BRPI0211993B8/en not_active IP Right Cessation
- 2002-08-13 MX MXPA04001677A patent/MXPA04001677A/en active IP Right Grant
- 2002-08-13 CN CNB028164385A patent/CN1239153C/en not_active Expired - Fee Related
- 2002-08-13 KR KR1020047002667A patent/KR100920599B1/en active IP Right Grant
-
2004
- 2004-01-15 ZA ZA200400312A patent/ZA200400312B/en unknown
-
2005
- 2005-03-11 HK HK05102131A patent/HK1069533A1/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002327831A1 (en) | Transdermal therapeutic system based on polyacrylate-contact-bonding adhesives without functional groups | |
HK1069533A1 (en) | Transdermal therapeutic system based on polyacrylate-contact-bonding adhesives without functional groups | |
AU2003247858A1 (en) | Improved cannula system | |
AU2003263000A1 (en) | Catheter anchor system | |
AU2003261085A1 (en) | Single system user identity | |
AU2003256813A1 (en) | Medical tele-robotic system | |
AU2002258186A1 (en) | Iontophoresis device | |
AU2003213659A1 (en) | Medical clip applier safety arrangement | |
AU2003279510A1 (en) | Adhesive anastomosis connection system | |
AU2003224725A1 (en) | Hiv therapeutic | |
PL352550A1 (en) | Transdermal therapeutic system employing neutralised pressure-sensitive acrylic adesives | |
AU2730600A (en) | Medical adhesives | |
AU2002328328A1 (en) | Transdermal therapeutic system with fentanyl or related substances | |
AU2002210463A1 (en) | Transdermal therapeutic system | |
AU2002353444A1 (en) | Integrated transdermal drug delivery system | |
AU2002332083A1 (en) | Guide-in-guide catheter system | |
AU2003241955A1 (en) | Steering system | |
AU2003212962A1 (en) | Transdermal drug delivery systems | |
AU2003270852A1 (en) | Patient positioning system | |
AU2003241134A1 (en) | Transdermal drug delivery system | |
AU2002220652A1 (en) | Pressure-sensitive adhesive | |
AUPR535101A0 (en) | Novel therapeutic molecules | |
AU2003272570A1 (en) | Dressing for catheter assembly | |
AU2002335667A1 (en) | Modified reoviral therapy | |
AU2002329530A1 (en) | Transdermal delivery system |